TrialCritical care (London, England)2010

Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock.

Herbert Spapen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.